Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

53 results about "Zoledronic acid" patented technology

This medication is used to treat high blood calcium levels (hypercalcemia) that may occur with cancer. Zoledronic acid is also used with cancer chemotherapy to treat bone problems that may occur with multiple myeloma and other types of cancer (such as breast, lung) that have spread to the bones.

Artificial bone for promoting osteoporotic bone defect repair and preparation method thereof

The invention discloses an artificial bone for promoting osteoporotic bone defect repair and a preparation method thereof, and belongs to the technical field of biomedical materials. The artificial bone disclosed by the invention is prepared by compounding the following components in percentage by weight: 89.65 to 89.85 weight percent of polylactic acid-glycolic acid copolymer, 9.85 to 10.15 weight percent of nano hydroxyapatite and 0.1 to 0.5 weight percent of zoledronic acid. In the artificial bone, the nano-hydroxyapatite and zoledronic acid are uniformly dispersed in the polylactic acid-glycolic acid copolymer, and the porous structure on the surface of the artificial bone is combined, so that osteoblasts can be attached to the surface of the artificial bone, and new bone tissues can grow in the artificial bone; phosphonate radicals of zoledronic acid can be chelated with nano-hydroxyapatite to generate stable chemical bonds, the stable chemical bonds are introduced into the polylactic acid-glycolic acid copolymer, effective loading of zoledronic acid can be achieved, and the effective loading of zoledronic acid can inhibit bone resorption increase caused by overactivation of osteoclasts and repair osteoporotic bone defects.
Owner:JILIN UNIVERSITY

Cell culture medium and preparation method of gamma delta T cell

The invention relates to the technical field of biological medicine, in particular to a cell culture medium and a preparation method of gamma delta T cells. The cell culture medium is a culture medium A or a culture medium B. The culture medium A comprises a serum-free culture medium, 1-100 [mu] M of zoledronic acid, 50-500 U / mL of IL-2, 1-5 [mu] M of imiquimod, 1-20 ng / mL of IL-15, 1-50 ng / mL of IL-1b, 10-100 ng / mL of IL-7 and 2-10% (v / v) of inactivated plasma or a serum substitute. The culture medium B comprises a serum-free culture medium, 100 to 2000 U / mL of IL-2, 1 to 50 ng / mL of IL-15, 1 to 10 [mu] M of zoledronic acid and 2 to 10% (v / v) of inactivated plasma or a serum substitute. By adopting the cell culture medium, a large number of gamma delta T cells can be rapidly obtained.
Owner:KANGLITAI BIOMEDICAL (QINGDAO) CO LTD

Gamma delta T cell culture method and culture medium

The invention provides a gamma delta T cell culture method and a culture medium, and belongs to the technical field of T cell culture. Modified nanoparticles, zoledronic acid, vitamin C and glutamine are added into a 1640 culture solution, the concentration of the modified nanoparticles ranges from 0.5 g / L to 1 g / L, the concentration of the zoledronic acid ranges from 0.5 mu mol / L to 1.5 mu mol / L, the concentration of the vitamin C ranges from 200 mu mol / L to 500 mu mol / L, and the concentration of the glutamine ranges from 0.1 mmol / L to 0.2 mmol / L. The prepared culture medium can efficiently stimulate amplification of the gamma delta T cells and improve the killing activity of the gamma delta T cells, meanwhile, the survival rate of the gamma delta T cells is also improved, and meanwhile, the culture method of the gamma delta T cells is simple, low in cost and wide in application prospect.
Owner:JILIN GUOJIAN LIFE ENG SCI TECH CO LTD

Method for detecting impurity A, impurity B, impurity C and impurity D in zoledronic acid bulk drug

The invention belongs to the technical field of medicine analysis, and particularly relates to a method for detecting an impurity A, an impurity B, an impurity C and an impurity D. High performance liquid chromatography is adopted for detection, and chromatographic conditions are as follows: a Titank Phenyl-Hexyl chromatographic column is adopted as a chromatographic column; acetonitrile and a buffer solution with the ratio of 4: 96 v / v are used as a mobile phase for isocratic elution, and every 1 L of the buffer solution contains 8.00 g of sodium 1-octanesulfonate, 37.00 mg of EDTA-disodium, 10 mL of perchloric acid and 2 mL of phosphoric acid; the flow velocity of the mobile phase is 0.6-1.0 mL / min, the column temperature is 15-25 DEG C, the sample size is 5-15 mL, an ultraviolet detector is used for detection, and the detection wavelength is 210-220 nm; the method can detect impurities A, B, C and D in the zoledronic acid bulk drug, and can be used for quality control of the zoledronic acid bulk drug.
Owner:JIANGSU ORIGINAL DRUG RES & DEV CO LTD

Preparation of zinc zoledronate micro-nanoparticle adjuvant and use thereof as vaccine adjuvant

Disclosed is a zinc zoledronate micro-nanoparticle adjuvant, which contains zinc and zoledronic acid and optionally contains a phosphate and aluminum. The preparation method therefor comprises performing mixed precipitation on a soluble salt solution containing zinc ions, zoledronic acid, and sodium hydroxide. The adjuvant can be used to prepare vaccines, etc.
Owner:XIAMEN UNIV +1

NKT cell in-vitro amplification method based on combined stimulant

The invention discloses an NKT cell in-vitro amplification method based on a combined stimulant, and belongs to the technical field of biology. The method comprises the following steps: firstly separating mononuclear cells in autologous peripheral blood, and then performing induced activation and amplification on the NKT cells in a serum-free culture system by adding a group A streptococcus preparation, a zoledronic acid preparation and a cytokine IL-2 as a combined stimulant. The method is easy to operate, efficient amplification of the NKT cells can be achieved only through three key reagents, the obtained NKT cells have the advantages of being large in number, high in purity, high in cytotoxicity and the like, and the requirements of clinical treatment can be met. Compared with a traditional method, the culture cost is remarkably reduced, the operation process is simplified, large-scale production, popularization and application are easy, and an efficient and economical technical scheme is provided for NKT cellular immunotherapy.
Owner:SHANDONG SAIENFU STEM CELL ENG GRP CO LTD

Polymer nanoparticle with bone targeting, acid environment neutralization and oxidation resistance characteristics and preparation method thereof

The invention relates to the field of high polymer materials and medical engineering, in particular to a high polymer nanoparticle with bone targeting, acid environment neutralization and oxidation resistance characteristics and a preparation method of the high polymer nanoparticle. The polymer nanoparticle is prepared from the following raw materials: a zoledronic acid modified polycaprolactone-polypeptide copolymer, the chemical structural formula of the copolymer is as follows: # imgabs0. The polymer nanoparticles prepared by taking the zoledronic acid modified polycaprolactone-polypeptide copolymer as a raw material have the advantages of bone targeting, excellent oxidation resistance and capability of neutralizing an acid environment. The polymer nanoparticles can exert significant efficacy (oxidation resistance and acid environment neutralization) for treating osteoporosis only by means of intrinsic activity of the materials of the polymer nanoparticles, so that a series of toxicity problems possibly caused by traditional drugs are substantially reduced fundamentally, and a brand new scheme is provided for treatment of osteoporosis.
Owner:TONGJI UNIV

A polymer nanoparticle with bone targeting, neutralizing acidic environment and antioxidant properties and a preparation method thereof

The present application relates to the field of high polymer material and medical engineering, and particularly relates to a high polymer nanoparticle with bone targeting, neutralizing acidic environment and antioxidant properties and a preparation method thereof. The preparation raw material of the high polymer nanoparticle comprises a zoledronic acid modified polycaprolactone-polypeptide copolymer, and a chemical structural formula of the copolymer is shown as follows: The high polymer nanoparticle prepared by using the zoledronic acid modified polycaprolactone-polypeptide copolymer as the raw material has the bone targeting, excellent antioxidant property and the ability of neutralizing acidic environment. The high polymer nanoparticle can exert the significant therapeutic effect (antioxidant, neutralizing acidic environment) of osteoporosis only by relying on the inherent activity of the material itself, so that a series of toxicity problems possibly caused by traditional drugs are fundamentally and greatly reduced, and a new scheme is provided for the treatment of osteoporosis.
Owner:TONGJI UNIV

A method for preparing CCR2+ gamma delta T cells with anti-tumor activity and migration ability

The application discloses a preparation method of CCR2+ gamma delta T cells with anti-tumor activity and migration ability, and belongs to the technical field of cells; the method comprises the following steps: step (1), PBMC of peripheral blood of a healthy person is extracted, inoculated into complete culture medium, and added with zoledronic acid, IL-15 and metformin, and then is cultured in a T25 culture bottle; step (2), complete culture medium is supplemented, the cell concentration is adjusted, and then the cells are transferred into a T75 culture bottle for culture; step (3), complete culture medium is supplemented, the cell concentration is adjusted, glucocorticoid and nicotinamide are added, and then the cells are transferred into a T150 culture bottle for culture; step (4), cells are collected at D6, rinsed with normal saline, resuspended with complete culture medium, the cell concentration is adjusted, and then the cells are inoculated into a T300 culture bottle for culture; and step (5), complete culture medium is supplemented every two days from D8 to D16, the cell concentration is maintained, and then the cells are harvested at D16 to obtain CCR2+ gamma delta T cells.
Owner:BEIJING WEICHUANG BOJING BIOTECHNOLOGY CO LTD

Detection method of zoledronic acid residual solvent

PendingCN119901824AComponent separationTheoretical plateOrganic solvent
The invention discloses a method for detecting a zoledronic acid residual solvent. The method comprises the following steps: (1) respectively preparing a blank solution, a reference solution and a test solution; (2) sample injection detection; an instrument is a gas chromatograph with a hydrogen flame ionization detector, nitrogen is used as carrier gas, and the carrier gas is injected into the gas chromatograph by adopting headspace sample injection; and respectively carrying out sample injection detection to obtain a chromatogram of the reference substance solution and a chromatogram of the test solution, and carrying out detection analysis by adopting an external standard method to complete the determination of the zoledronic acid residual solvent. According to the method, the gas chromatograph is adopted to detect the residues of methanol, tetrahydrofuran, isopropanol and triethylamine in zoledronic acid, the detection chromatographic conditions are optimized in a targeted manner, and under the condition of ensuring good theoretical plate and separation degree, a plurality of residual solvents are placed in the same system for detection, so that the detection efficiency is greatly improved; and meanwhile, the detection chromatographic conditions are specifically optimized, so that the organic solvents are completely separated, and the linear relation is good in the investigated range.
Owner:CHANGZHOU FANGYUAN PHARMA

Method for culturing human umbilical cord mesenchymal stem cells

The invention provides a culture method of human umbilical cord mesenchymal stem cells, and belongs to the technical field of cell culture. The method comprises the following steps: firstly, constructing an activation culture medium aiming at an initial culture stage and an amplification culture medium aiming at an amplification culture stage; wherein the activation culture medium takes alpha-MEM containing 10% of fetal calf serum as a basic culture medium, and alpha-tocopherol, nicotinic acid and gypenoside are added as additives, so that the cell amplification efficiency in the initial stage can be fully improved; a serum-free scheme is adopted for an amplification culture medium, RPMI-1640 is taken as a basic culture medium, and glutamine, rhG-CSF, bFGF, VEGF, transferrin, vitamin C, 2-mercaptoethanol, zoledronic acid, lenalidomide, ethanolamine and sodium selenite with specific amounts are added, so that the cell amplification speed in an amplification culture stage is remarkably increased. On the basis, a three-stage amplification process is adopted, and large-scale culture of the umbilical cord mesenchymal stem cells is realized. The method is short in culture time and high in cell quantity accumulation speed, and the culture efficiency is remarkably improved.
Owner:中泽赛奥(海南)生物科技有限公司

Therapeutic treatment of breast cancer based on c-MAF status

To provide a therapeutic treatment of breast cancer based on c-MAF status.SOLUTION: The present invention relates to the design of a customized therapy for a subject with breast cancer based on the c-MAF expression level and the menopausal status of the subject. In some embodiments, the customized therapy comprises an agent for avoiding or preventing bone degradation. In some embodiments, the agent for avoiding or preventing bone degradation is zoledronic acid. In one aspect, provided is an in vitro method for designing a customized therapy for a subject having breast cancer. The method comprises: (i) quantifying the c-MAF gene expression level, copy number, amplification, or gain in a sample of the subject; and (ii) comparing the expression level, copy number, amplification, or gain obtained in (i) with a reference value.SELECTED DRAWING: None
Owner:INBIOMOTION

Extraction method of high-performance gamma delta T immune cells and application of high-performance gamma delta T immune cells in tumors

The invention provides an extraction method of high-performance gamma delta T immune cells and application of the high-performance gamma delta T immune cells in tumors. The method comprises the following steps: firstly, separating mononuclear cells from peripheral blood, carrying out activation induction by using a serum-free culture medium containing zoledronic acid, IL-15 and OKT3, and supplementing a culture medium containing IL-2 according to a specific proportion for multiplication culture from the third day of culture. Through the optimization process, the expression rate of TCR-gamma delta < + > is as high as 96.84%, and gamma delta T cells with high activity are obtained. An in-vivo tumor inhibition experiment shows that the cell has a remarkable growth inhibition effect on liver cancer nude mouse transplanted tumor, the effect is equivalent to that of a positive control drug, and obvious toxic and side effects are not observed. The method is stable in process and clear in component, and a reliable technical basis is provided for clinical transformation of gamma delta T cells in immunotherapy of solid tumors and hematologic tumors.
Owner:HEBEI STEM CELL INTELLIGENT MEDICAL TECH GRP CO LTD

A method and culture medium for γδ T cells

The application provides a kind of gamma delta T cell culture method and culture medium, belong to T cell culture technical field.In 1640 culture solution is added modified nanoparticle, zoledronic acid, vitamin C, glutamine, wherein, the concentration of the modified nanoparticle is 0.5-1g / L, the concentration of the zoledronic acid is 0.5-1.5 μmol / L, the concentration of the vitamin C is 200-500 μmol / L, the concentration of the glutamine is 0.1-0.2 mmol / L.The culture medium prepared by the application can efficiently stimulate gamma delta T cell expansion and improve its killing activity, and the survival rate of gamma delta T cells is also improved, and the culture method of gamma delta T cells is simple, the cost is low, and has broad application prospect.
Owner:JILIN GUOJIAN LIFE ENG SCI TECH CO LTD

Pharmaceutical composition for treating drug-resistant bacterial infection and application thereof

The invention relates to an antibacterial drug, in particular to a pharmaceutical composition for treating drug-resistant bacterial infection and application of the pharmaceutical composition, including application of bacterial carbamyl phosphonic acid synthase as an antibacterial drug target in preparation of the pharmaceutical composition for treating and resisting drug-resistant bacterial infection. The antibacterial pharmaceutical composition comprises polymyxin antibiotics, zoledronic acid or pharmaceutically acceptable salts thereof, and a hydrous compound. According to the invention, a key enzyme CarB participating in an arginine biosynthetic pathway or a pyrimidine metabolic pathway in polymyxin drug-resistant bacteria is used as a target, and zoledronic acid as an inhibitor of CarB enzyme activity or a pharmaceutically acceptable salt and a hydrous compound thereof are used as synergists of polymyxin; the pharmaceutical composition of polymyxin and zoledronic acid can effectively inhibit the growth of gram-negative bacteria in vivo and in vitro. The zoledronic acid can obviously reduce the effective use dosage of the polymyxin antibiotics and reduce the toxic and side effects of the polymyxin antibiotics in clinical use. The invention can provide a new strategy for clinical treatment and application of anti-polymyxin drug-resistant bacterial infection.
Owner:CHINA PHARM UNIV

Combination vectors and methods for treating cancer

A composition for treating cancer is disclosed. The composition includes a lentiviral particle and an aminobisphosphonate drug. The lentiviral particle is capable of infecting a target cell, such as a cancer cell, and includes an envelope protein optimized for targeting such target cell and a viral vector. The viral vector includes a small RNA optimized to target an FDPS mRNA sequence. The aminobisphosphonate drug includes zoledronic acid.
Owner:AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC

A nano-aluminum formulation of doxorubicin / zoledronic acid, its preparation method and application

This invention discloses a nano-aluminum formulation of doxorubicin / zoledronic acid, its preparation method, and its application. The preparation method includes the following steps: S1: Adding an aqueous solution of zoledronic acid with a pH of 4-6 to the aqueous solution of nano-aluminum, stirring to obtain zoledronic acid-nano-aluminum; S2: Adding an aqueous solution of doxorubicin to the aqueous solution of zoledronic acid-nano-aluminum, stirring to obtain the doxorubicin / zoledronic acid nano-aluminum formulation. The DOX / ZA-Al-nano formulation of this invention can effectively inhibit tumor cell growth by promoting greater entry of doxorubicin into cells and rapid entry into the cell nucleus, and can be used for the combination therapy of osteosarcoma. Furthermore, the preparation method of this invention is simple, the reaction conditions are mild, and it is easy to operate, optimizing the preparation process and application scheme of nano-aluminum, and has the prospect of industrialization.
Owner:NANJING TECH UNIV

Therapeutic treatment of breast cancer based on c-MAF status

The present invention relates to the design of a customized therapy for a subject with breast cancer based on the c-MAF expression level and the menopausal status of the subject. In some embodiments, the customized therapy comprises an agent for avoiding, treating or preventing bone degradation. In some embodiments, the agent for avoiding, treating or preventing bone degradation is zoledronic acid. In other embodiments, the agent is clodronate or denosumab.
Owner:INBIOMOTION

Culture medium for in-vitro amplification and activation of gamma delta T cells, culture method and application of culture medium

The invention discloses a culture medium for in-vitro amplification and activation of gamma delta T cells, a culture method and application of the culture medium, and belongs to the technical field of in-vitro culture of immune cells. The culture medium comprises zoledronic acid, interleukin-2 (IL-2), wnt / beta-catenin signaling pathway activators (GSK-3alpha and GSK-3beta specific inhibitors), particularly 6-bromo indirubin-3 '-acetoxime (Bio-acetoxime), peripheral blood mononuclear cells (PBMC) can be used as a starting material, gamma delta T cells can be separated from the PBMC through amplification for 14 days, high-purity gamma delta T cells can be efficiently and repeatedly generated, and high-purity gamma delta T cells can be obtained. The yield of the gamma delta T cell can be obviously improved, the obtained gamma delta T cell has the functions of a T cell, an NK cell and an antigen presenting cell, and the anti-tumor efficiency is also obviously improved.
Owner:NANJING YITUO BIOTECHNOLOGY CO LTD

Preparation method of zoledronic acid dimer

The invention belongs to the technical field of medicine synthesis, and discloses a preparation method of zoledronic acid dimer impurities. The preparation method is novel, simple to operate, high in product purity and suitable for industrial production; the zoledronic acid dimer impurity synthesized by the invention can be used as a standard substance for detecting zoledronic acid raw material medicines and preparations, so that the accuracy of impurity content detection and analysis is improved, the impurity in the zoledronic acid raw material medicines and preparations is favorably controlled, and the quality of zoledronic acid finished products is further improved.
Owner:SHANDONG NEW TIME PHARMA CO LTD

A staged precise regulation in vitro expansion culture method of high-activity γδ T cells

The application belongs to the technical field of biotechnology, and particularly relates to a staged precise regulation in vitro expansion culture method of high-activity gamma delta T cells. In the synergistic activation stage, the complex activator containing zoledronic acid, IL-2, IL-15, IL-12 and IL-21 is used to significantly improve the early activation level of the gamma delta T cells; in the dynamic expansion stage, the concentration of metformin is adjusted step by step to support the continuous and efficient proliferation of the cells; in the gradient maturation stage, the combination system of N-acetyl cysteine, TWS119 and DL-alpha tocopheryl acetate is introduced to help maintain the functional activity and antioxidant state of the cells in the later culture stage. The gamma delta T cells with a purity higher than 90% and an expansion multiple more than 100 times can be obtained by using the method to culture for 10 days, and the cells exhibit significant killing activity to tumor cells, are suitable for the adoptive immunotherapy of tumor and infectious diseases, and have good clinical application prospects.
Owner:SHANDONG SAIENFU STEM CELL ENG GRP CO LTD +1

Bone-targeting metal organic framework medicine loaded with traditional Chinese medicine component composition and preparation method of bone-targeting metal organic framework medicine

The invention discloses a bone targeting metal organic framework medicine loaded with a traditional Chinese medicine component composition and a preparation method thereof, and the medicine comprises a bone targeting metal organic framework medicine carrier and a traditional Chinese medicine active component composition loaded on the bone targeting metal organic framework medicine carrier, the traditional Chinese medicine active ingredient composition is a composition formed by compatibility of astragaloside, icariin and notoginsenoside R1. The preparation method comprises the following steps: (S1) preparing the Dyg-coated UiO-66-NH2; (S2) preparing the Dyg-coated UiO-66-NH2; s2, preparing activated zoledronic acid; and S3, preparing the Dyg (at) UiO-66-ZOL. The bone targeting metal organic framework medicine loaded with the traditional Chinese medicine component composition is good in biocompatibility, has a promoting effect on cell relative activity of PMOP OB, reduces toxic and side effects caused by too high medicine concentration, has a promoting effect on differentiation and mineralization of PMOP OB, and has a bone targeting effect in vivo and in vitro.
Owner:GUANGDONG MEDICAL UNIV

Zoledronic acid hollow nanosphere, zoledronic acid hollow nanosphere loaded paclitaxel anti-tumor material and preparation method and application of zoledronic acid hollow nanosphere loaded paclitaxel anti-tumor material

The invention discloses a zoledronic acid hollow nanosphere, a zoledronic acid hollow nanosphere loaded paclitaxel antitumor material and a preparation method and application thereof, the preparation method of the zoledronic acid hollow nanosphere comprises the following steps: dispersing a zeolite imidazole framework 8 in methanol, adding an aqueous solution of zoledronic acid, standing for 60-180 min, centrifuging and cleaning to obtain the zoledronic acid hollow nanosphere loaded paclitaxel antitumor material. The zoledronic acid hollow nanospheres are obtained; the zoledronic acid hollow nanosphere loaded paclitaxel antitumor material can be prepared by loading paclitaxel on the zoledronic acid hollow nanosphere. According to the anti-tumor material, the synergistic anti-tumor effect of the zoledronic acid hollow nanospheres and the paclitaxel can be effectively exerted, and breast cancer cells MCF-7 can be remarkably killed.
Owner:WANNAN MEDICAL COLLEGE

Combination vectors and methods for treating cancer

A composition for treating cancer is disclosed. The composition includes a lentiviral particle and an aminobisphosphonate drug. The lentiviral particle is capable of infecting a target cell, such as a cancer cell, and includes an envelope protein optimized for targeting such target cell and a viral vector. The viral vector includes a small RNA optimized to target an FDPS mRNA sequence. The aminobisphosphonate drug includes zoledronic acid.
Owner:AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC

A preparation method of zoledronic acid impurity B

The invention discloses a method for preparing zoledronic acid impurity B, comprising the following steps: ① preparing intermediate I by nucleophilic substitution of imidazole and halogenated acetic acid ester, ② hydrolyzing and purifying intermediate I to prepare intermediate II; ③ preparing zoledronic acid impurity B; adding intermediate II, phosphoric acid or phosphorous acid, and solvent into a reaction container, stirring and heating to 35±5°C; dropping phosphorus trichloride into the reaction container, heating to 65±5°C and reacting for 3-5h after the addition; cooling to room temperature after the reaction of this part, dropping water into the material, heating to 95±5°C and reacting for 2-3h after the addition, and the reaction ends; cooling the reaction system and purifying to obtain zoledronic acid impurity B. The invention improves the reaction route and process of zoledronic acid impurity B, screens a series of influencing factors such as reaction raw materials, solvent type, reaction temperature, equivalent number, system concentration, etc., and the obtained product has a purity of>98%, which can be used as a reference substance.
Owner:CHANGZHOU FANGYUAN PHARMA

Application of bisphosphonate compound in preparation of antigen-specific activated T cell preparation

The invention discloses an application of a bisphosphonate compound in preparation of an antigen-specific activated T cell preparation. The bisphosphonate compound is etidronate sodium as shown in a formula I; the clodronate sodium is shown as a formula II; the pamidronate sodium is shown as a formula III; the alendronate sodium trihydrate is as shown in a formula IV; zoledronic acid is as shown in formula V; the ibandronic acid is as shown in a formula VI; the risedronate sodium is shown as a formula VII; minodronic acid is shown as a formula VIII. The bisphosphonate compound can specifically activate T cells and remove target cells, and the target cells comprise various tumor cells, aging cells and infected cells.
Owner:YUNNAN UNIV

Ultralow dose zoledronic acid for treatment of retinal diseases

PendingCN119546310AOrganic active ingredientsSenses disorderDiseaseAcid sphingomyelinase
Provided herein are methods of treating retinal diseases using low doses of bisphosphonate hydrosphingomyelinase (ASM) and a farnesyl diphosphate synthase (FDPS) inhibitor, such as zoledronic acid.
Owner:RGT UNIV OF CALIFORNIA +1

A strontium ion / zoledronic acid-loaded composite gel and a method for preparing the same

The application belongs to the technical field of biomedical materials, and provides a composite gel loaded with strontium ions / zoledronic acid and a preparation method thereof, which comprises the following steps: preparing thiol-modified sodium hyaluronate and double bond-modified carboxymethyl chitosan; preparing strontium ion-doped mesoporous silica microspheres, thiol-modified strontium ion-doped mesoporous silica microspheres and thiol-modified strontium ion-doped mesoporous silica microspheres loaded with zoledronic acid in sequence; dissolving the thiol-modified sodium hyaluronate and the double bond-modified carboxymethyl chitosan in deionized water respectively, and then stirring and mixing the thiol-modified sodium hyaluronate, the double bond-modified carboxymethyl chitosan and the thiol-modified strontium ion-doped mesoporous silica microspheres loaded with zoledronic acid, and adding a photoinitiator and irradiating under ultraviolet light. The composite gel prepared by the application integrates mechanical support, biocompatibility, intelligent drug release and synergistic osteogenesis / angiogenesis, and can be applied to the preparation of high-performance osteoporotic bone defect repair materials.
Owner:JILIN UNIVERSITY

Use of arginine and pharmaceutical composition containing arginine

PCT designated stage expiredWO2025112946A1Organic active ingredientsAntipyreticDiseaseArginine
The present invention relates to the use of arginine, and a pharmaceutical composition containing arginine. First, provided in the present invention is an inflammation model successfully constructed by using zoledronic acid. The model can be used for screening a drug for inflammation-related diseases, thereby facilitating for research on inflammation-related mechanisms and pharmaceutical development. The construction method has good repeatability and stability. Further provided in the present invention is the use of arginine and a pharmaceutical composition thereof. Studies show that both arginine and the composition of arginine and zoledronic acid can effectively treat, prevent and / or relieve side reactions such as renal injury, and inflammation that occurs during the treatment by using zoledronic acid.
Owner:CHONGQING MEDICAL UNIVERSITY